Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - MERIDIAN BIOSCIENCE INC | c93071e10vk.htm |
| EX-23 - EXHIBIT 23 - MERIDIAN BIOSCIENCE INC | c93071exv23.htm |
| EX-13 - EXHIBIT 13 - MERIDIAN BIOSCIENCE INC | c93071exv13.htm |
| EX-31.1 - EXHIBIT 31.1 - MERIDIAN BIOSCIENCE INC | c93071exv31w1.htm |
| EX-31.2 - EXHIBIT 31.2 - MERIDIAN BIOSCIENCE INC | c93071exv31w2.htm |
| EX-10.23 - EXHIBIT 10.23 - MERIDIAN BIOSCIENCE INC | c93071exv10w23.htm |
| EX-10.38 - EXHIBIT 10.38 - MERIDIAN BIOSCIENCE INC | c93071exv10w38.htm |
| EX-10.39 - EXHIBIT 10.39 - MERIDIAN BIOSCIENCE INC | c93071exv10w39.htm |
| EX-10.16 - EXHIBIT 10.16 - MERIDIAN BIOSCIENCE INC | c93071exv10w16.htm |
| EX-21 - EXHIBIT 21 - MERIDIAN BIOSCIENCE INC | c93071exv21.htm |
Exhibit 32
Certification of Chief Executive Officer and Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the filing with the Securities and Exchange Commission of the
Annual Report of Meridian Bioscience, Inc. (the “Company”) on Form 10-K for the period
ended September 30, 2009 (the “Report”), the undersigned officers of the Company,
certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that to the best of their knowledge:
| 1. | The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and |
||
| 2. | The information contained in the Report fairly presents, in
all material respects, the financial condition and results of operations of
the Company. |
/s/ John A. Kraeutler
John A. Kraeutler
Chief Executive Officer
November 30, 2009
John A. Kraeutler
Chief Executive Officer
November 30, 2009
/s/ Melissa Lueke
Melissa Lueke
Executive Vice President and
Chief Financial Officer
November 30, 2009
Melissa Lueke
Executive Vice President and
Chief Financial Officer
November 30, 2009